ATS Busts Drug Export Racket: 22 Kg Etomidate Seized, Two Arrested Including Nikunj

Ahmedabad / Surat:  The Gujarat Anti-Terrorism Squad (ATS) has busted an international drug export racket and arrested two key accused, including Surat-based businessman Nikunj Gadhiya, in connection with the illegal export of the anesthetic drug etomidate.

According to ATS officials, around 22 kg of etomidate stock was seized during the investigation after suspicious consignments were intercepted at Chhatrapati Shivaji Maharaj International Airport in Mumbai. The drug had been falsely labelled as “aloe vera powder” to evade customs checks before being shipped abroad through air cargo.

Investigators revealed that Nikunj Gadhiya and his associates allegedly purchased large quantities of the drug and exported it using fake invoices and forged customs documents through companies such as DWN Bioscience, Neutral Pharma and Om Herbs. The consignments were reportedly destined for Malaysia, Thailand and Singapore, where etomidate is treated as a controlled narcotic substance.

During interrogation, ATS officials discovered that the accused were in contact with international drug cartels operating in Southeast Asia. Authorities estimate that more than 125 kg of etomidate had already been exported earlier through similar methods before the racket was exposed.

Officials also noted that etomidate is not currently listed under India’s NDPS Act, a loophole that traffickers allegedly exploited to procure and export the drug while misdeclaring it as cosmetic or herbal ingredients. Further investigation is underway to identify the overseas network and financial trail linked to the operation.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre